28 October
Non-commercial clinical trials as a chance to improve patient health care - WE! are the clinical research

The clinical trials market in Poland is mostly based on commercial clinical trials. Meanwhile, this type of research does not work, for example, in the case of the development of treatments for rare diseases or pediatric groups. As a rule, these are not areas of interest to pharmaceutical companies for business reasons. Small research groups, difficulties in conducting and long duration of research in these groups forced the search for sources of financing outside the pharmaceutical industry, and thus the development of non-commercial clinical trials. So, who can sponsor non-commercial clinical trials? What role do patient groups play in this process? Where to find financing? Why in other countries, such as France, Great Britain, Czech Republic, Denmark or Switzerland, they account for nearly 50% of all clinical trials conducted during the year? Why are they called academic? How to start a non-commercial clinical trial? And finally… how can they contribute to the improvement of the health care system and the development of science in Poland and in the world?

As part of our organization WE! Are the clinical research, we invite you to the hybrid seminar on October 28, 2021, at 6.00 pm, which will be led by Anna Jaworska and Beata Maciejewska from Scientia Research Institute Sp. z o.o., during which we will present the subject of non-commercial clinical trials and their impact on science and the health care system. Prof. Anna Raciborska (head of the Department of Oncology and Oncological Surgery of the Institute of Mother and Child in Warsaw) and prof. Jan Styczyński (National Consultant in the field of pediatric oncology and hematology), will present their meaning from their perspective.


We hope that the meeting will inspire the development and strengthening of international cooperation in the field of non-commercial clinical trials.

Organizational matters

Time and place: Thursday, October 28, 2021 at 10:00 p.m. 18:00.

Live - Aula Leona Koźmińskiego, ul Jagiellońska 57, 03-301 Warsaw.

Online - Zoom Meeting.

The seminar will be conducted in Polish. Technical issues will be communicated to those registered with a link to the event.

We act and support!

Every activity of the WE! Are the Clinical Research Movement is associated with the support of the Koźmiński Foundation, whose goals include activities for the development of science, education, upbringing and upbringing as well as supporting gifted youth.

The cost of participation in the Seminar is PLN 50, and the entire amount collected is allocated to the activities of the Koźmiński Foundation.

See you at the Seminar!

How to register?:
Sign in!
Anna Jaworska
Dr. n. med. Anna Jaworska

Anna Jaworska,PhD, Clinical Research Associate at CRO Scientia Research Institute Sp. z o.o. In the years 2003 - 2013 she was associated with the Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, initially as a student of medical biotechnology. The following years she devoted to research work in the field of flow cytometry and pediatric hematooncology at the Department of Paediatrics, Haematology and OncologyIn 2013, she obtained the title of Doctor of Medical Sciences on the basis of the dissertation "Minimal residual disease in acute leukemias in children". Since 2011, she has also been associated with the pharmaceutical industry in various therapeutic areas (cardiology, diabetology, pulmonology and ophthalmology). Graduate of Postgraduate Studies at Kozminski University, Conducting and Monitoring Clinical Trials. Member of the GCPpl Association and passionate about non-commercial clinical trials.

Beata Maciejewska
Dr. n. biol. Beata Maciejewska

Beata Maciejewska Ph.D., Clinical Operations Director and President of the Board CRO Scientia Research Institute Sp. z o.o. In the past engaged as the researcher at the Polish Academy of Science in Olsztyn and then at the Nicolaus Copernicus University in Toruń. Since 2003 she specialized in the field of clinical trials in all phases in the different therapeutical indications (cardiology, neurology, oncology, vaccines, diabetology, pediatric trials). She has experience in the management of the CRO companies and conducting the projects, providing quality assurance, trainings and building the team of qualified and dedicated professionals in the field of clinical trials. Member of the Board Polish Association for the Good Clinical Practice GCPpl and coordinator of the working group non-commercial clinical trials.